Back to Journals » International Journal of High Throughput Screening » Volume 1

A novel cell-based 384-well, label-free assay for discovery of inhibitors of influenza A virus

Authors Fuli Jia, Clinton Maddox, Alice Gao, et al

Published 12 May 2010 Volume 2010:1 Pages 57—67

DOI https://doi.org/10.2147/IJHTS.S8893

Review by Single-blind

Peer reviewer comments 2

Fuli Jia1, Clinton Maddox2, Alice Gao3, Louie Tran3, William Severson1, E Lucile White2, Lynn Rasmussen2, Anju Dang3, Colleen B Jonsson1,4

1Department of Biochemistry and Molecular Biology, Southern Research Institute, Birmingham, AL, USA; 2High-Throughput Screening Center, Southern Research Institute, Birmingham, AL, USA; 3Corning Life Science, Corning, NY, USA; 4Department of Microbiology and Immunology, University of Louisville, Louisville, KY, USA

Abstract: Resonance wave-guide (RWG) biosensor technology allows label-free measurements of global cellular responses of the dynamic mass redistribution (DMR). We hypothesized that the DMR signals to extracellular stimulations occurring upon entry of a virus, could provide a new approach for the development of physiologically relevant cell-based assays for screening of small molecules. We explored this technology with influenza virus (A/Udorn/72, H3N2) using MDCK and Vero E6 cell lines in a 384-well format. The MDCK cell line assay was optimized with a fibronectin-coated surface microplate with 6000 cells per well that were infected at a multiplicity of infection (MOI) of 1. Under this set of optimized conditions, for the vero E6 cells, an assay window of 1130 pm shift were obtained at 24 hours. The Vero E6 cell line assay was optimized using a poly-D-lysine-coated surface with seeding density of 6000 cells per well that were infected at a MOI of 5. Under this set of optimized conditions for the MDCK cells, an assay window of >600 units and Z values of 0.6–0.7 were obtained at 24 h. A small library of 1120 compounds was screened using the MDCK, which demonstrates the feasibility of the approach for high-throughput screening.
Keywords: small molecule screening, label-free technology, antivirals

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

A novel preparation method for silicone oil nanoemulsions and its application for coating hair with silicone

Hu Z, Liao M, Chen Y, Cai Y, Meng L, Liu Y, Lv N, Liu Z, Yuan W

International Journal of Nanomedicine 2012, 7:5719-5724

Published Date: 12 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010